The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related decrease in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study included about 800 older men with low testosterone and symptoms associated with this illness, for example http://tinyurl.com/zq3zb78 physical and sexual dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.

The recent contradictory findings on testosterone treatment prompted Patel and his team to conduct a sizeable systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in America have problems with low testosterone, which happens when the body doesn't make enough hormones because of a problem with the testicles or pituitary gland. This explains clear aging, a person's unexpected weight gain and decline of energy.

No clear lower limit of testosterone has been confirmed; however 15 ng per dL (0.5 nmol per L) usually is used. One study 38 found that girls with 0 to 10 ng per dL (0 to 0.3 nmol per L) had markedly decreased sexual desire in all situations and absent or markedly decreased climaxes. As a result of studies similar to this, supplemented with anecdotal evidence, many girls have been started on testosterone therapy. Most girls can expect to spend one third of their lives in the postmenopausal stage. Depression, anger, moodiness, insomnia, and lack of well being are common criticisms of postmenopausal women.